Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |